NCT06743581
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Centre hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
- CHUM Montreal, Quebec, Canada
Clinical trial condition
Neoadjuvant Therapy
Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.
120 public trials
46 recruiting studies
Neoadjuvant Therapy trial results
NCT07695259
- Conditions
- Breast Diseases, Breast Neoplasms, Elderly Females, +6 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT07601737
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head & Neck Cancer, +9 more
- Locations
-
- Shanghai First People's Hospital Shanghai, China
Recruiting
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
NCT07359040
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06758830
- Conditions
- Chemoradiotherapy, Chemotherapy, Chemotherapy Side Effects, +27 more
- Locations
-
- Nacional Cancer Institute Vilnius, Lithuania
NCT07541664
- Conditions
- Neoadjuvant Therapy
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
NCT06281405
- Conditions
- Locally Advanced Rectal Cancer, Neoadjuvant Therapy
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT07498933
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT07289282
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Istanbul Atlas University Faculty of Medicine Istanbul, Turkey (Türkiye)
NCT07492342
- Conditions
- KRAS G12C Mutation, Neoadjuvant Therapy, Resectable NSCLC, +1 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
- The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- The First Affiliated Hospital of Zhejiang University School of Medicine Zhejiang, China